Rethinking Newborn Screening for Critical Congenital Heart Disease Newborn screening for critical congenital heart disease (CCHD) has evolved significantly since its initial implementation, with updated guidelines aiming to improve detection while reducing unnecessary follow-ups. Current recommendations focus on using pulse oximetry to identify infants with low oxygen saturation levels before hospital discharge, enabling early intervention that can prevent disability or death. The screening process measures oxygen saturation in the blood using a non-invasive pulse oximeter. According to current guidelines, screening should be performed when a baby is at least 24 hours of age or as late as possible if discharge is planned before 24 hours. This timing allows for adequate physiological transition after birth while still occurring prior to hospital discharge. A key update to the screening algorithm involves adjusting the passing threshold and retest protocol. The updated approach requires oxygen saturation readings of at least 95% in both pre-ductal (right hand) and post-ductal (either foot) measurements for a passing result. Infants who do not meet this threshold on initial screening now receive only one additional retest, rather than two, streamlining the process while maintaining diagnostic accuracy. This screening method identifies several types of critical congenital heart defects, including hypoplastic left heart syndrome, pulmonary atresia, tetralogy of Fallot, total anomalous pulmonary venous return, transposition of the great arteries, tricuspid atresia and truncus arteriosus. While pulse oximetry screening is effective at detecting hypoxemia associated with these conditions, it should complement—not replace—comprehensive clinical evaluation including family history, pregnancy history, and physical examination. Research indicates that mandated CCHD screening using pulse oximetry has reduced early infant deaths from critical congenital heart defects by approximately 33%, equating to about 120 deaths prevented annually in the United States. This significant impact underscores the value of systematic screening programs in improving newborn outcomes. State newborn screening programs are encouraged to collect standardized surveillance data to monitor program effectiveness and identify areas for improvement. Ongoing education for healthcare providers about screening limitations, the importance of protocol adherence, and recognition of non-cardiac conditions that may cause low oxygen saturation remains essential for optimal implementation. As screening practices continue to evolve, efforts focus on enhancing sensitivity, reducing health disparities in access to screening and follow-up care, and ensuring consistent application of evidence-based guidelines across all birth settings. The continued collaboration between professional organizations, public health agencies, and healthcare facilities remains vital to maintaining and improving the effectiveness of CCHD screening programs nationwide.
6